Quantcast

Latest Benign prostatic hyperplasia Stories

2014-07-08 23:14:27

HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution agreement through its Endocare, Inc. subsidiary with HS Medical, Inc. that expands HealthTronics’ technology portfolio to include a new, targeted ablation solution. Austin, Texas (PRWEB) July 08, 2014 HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution...

2014-07-02 08:27:35

Testosterone Gel (1%), the Generic Equivalent to Vogelxo(TM) (testosterone) Gel, Expected to Increase Access for Patients Who Need It MAPLE GROVE, Minn., July 2, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced the launch of Testosterone Gel (1%), the generic of the newly Food and Drug Administration (FDA) approved Vogelxo((TM)) (testosterone) gel 1%, for topical use, CIII, and the first and only available generic testosterone replacement therapy (TRT) available in three...

2014-06-19 23:16:34

NCMA’s Santa Rosa Urology and Dr. Michael Lazar provide diagnostics, treatment and management of a full spectrum of urologic health conditions including bladder stones. (PRWEB) June 19, 2014 Bladder stones are exactly what they sound like; hard stone-like pieces of concentrated urine which have crystallized and clumped together. Interestingly enough, in developing nations, bladder stones are fairly common in children – and sadly, as a result of dehydration, infection and a low-protein...

2014-06-09 12:29:27

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Japanese Urological Devices Markethttp://www.reportbuyer.com/pharma_healthcare/medical_supplies/hospital_supplies/japanese_urological_devices_market.html In 2012, the Japanese market for urological devices was valued at $411.9 million.This report analyzes the markets for the treatment of benign prostate hyperplasia (BPH), prostate cancer, urinary incontinence as well as urinary and kidney...

2014-05-30 12:25:59

WASHINGTON, May 30, 2014 /PRNewswire-USNewswire/ -- LUGPA will celebrate June as the start of Men's Health Month, urging men to take control of their health by educating themselves on important health issues. "Studies show that men are more likely to avoid going to the doctor than women, leaving them at the mercy of an unimaginable number of diseases and conditions that could have been prevented or improved if only they had talked to their doctor," said Dr. Juan Reyna, president of...

2014-05-28 20:22:42

Natesto(TM) is the first nasal testosterone replacement therapy approved by FDA TORONTO, May 28, 2014 /CNW/ - Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the United States Food and Drug Administration (FDA) has approved Natesto(TM) (testosterone), formerly CompleoTRT(TM), the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Natesto(TM) is...

2014-05-27 08:27:46

-- High calibre German consulting company appointed to assist CE Mark registration process SYDNEY, May 27, 2014 /PRNewswire/ -- Australian biotechnology company Minomic International Limited will register its MiStat(TM) ELISA prostate cancer test for CE Mark approval in the latter part of 2014. Achieving CE approval will be a key commercial milestone for the company, allowing it to sell and market its early detection diagnostic technology in the 33 member countries within the...

2014-05-18 12:20:18

Panel discusses changes in a man's sexual function after a bilateral nerve-sparing radical prostatectomy and in those with LUTS/BPH ORLANDO, Fla., May 18, 2014 /PRNewswire-USNewswire/ -- Two studies evaluating the sexual function in men with Lower Urinary Tract Symptoms (LUTS) as well as post bilateral nerve-sparing radical prostatectomy will be presented to the media at a special press conference during the 2014 Annual Scientific Meeting of the American Urological Association (AUA). Tobias...

2014-05-14 08:26:33

NEW YORK, May 14, 2014 /PRNewswire/ -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) specializes in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the aging population. The Company has just completed its second Phase 3 clinical trial for its new drug for benign prostatic hyperplasia (BPH). Nymox has a number of drugs in development for other indications such as E. coli infection, Alzheimer's...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related